RESUMEN
Herbicides glyphosate (N-(phosphonomethyl)glycine) and glufosinate (2-amino-4-(hydroxymethylphosphinyl)butanoic acid) and the main transformation product of glyphosate, aminomethanephosphonic acid (AMPA), are challenging to analyze for in environmental samples. The quantitative method developed by this study adapts previously standardized dechlorination procedures coupled to a novel charged surface C18 column, ultra-high performance liquid chromatography-tandem mass spectrometry, polarity switching, and direct injection. The method was applied to chlorinated tap water, as well as river samples, collected in the City of Winnipeg and rural Manitoba, Canada. Using only syringe filtration without derivatization, the validated method resulted in good accuracies in both tap and surface water, at both 2 and 20 µg L-1. Method limits of detection (MLD) and quantification (MLQ) ranged from 0.022/0.074 to 0.11/0.36 µg L-1, with precisions of 0.46-2.2% (intraday) and 1.3-7.3% (interday). The mean (SEM) of the pesticides in µg L-1 for tap water were 0.11 (0.007) (AMPA), glufosinate and glyphosate < MLDs; and for Red River water were 0.56 (0.045) (AMPA), glufosinate < MLQ, and glyphosate 0.40 (0.072). For the smaller tributaries, glufosinate was >MLD but < MLQ once and that was for Shannon Creek at 0.2 µg L-1. For the remaining rivers, the mean concentrations ranged from 0.31 to 3.1 µg L-1 for AMPA, and 0.087-0.53 µg L-1 for glyphosate. The method will be ideal for supporting monitoring and risk assessment programs that require high throughput sampling and quantitative methods capable of producing robust results that leverages chromatographic and mass spectrometric paradigms instead of being extraction technology focused.
Asunto(s)
Agua Potable , Herbicidas , Glifosato , Cromatografía Líquida de Alta Presión , Agua Potable/análisis , Ácido alfa-Amino-3-hidroxi-5-metil-4-isoxazol Propiónico/análisis , Espectrometría de Masas en Tándem/métodos , Herbicidas/análisisRESUMEN
Ultraviolet filters (UVFs) absorb UV light and are comprised of numerous classes of compounds including inorganic and organic. They have been used for decades in protecting humans from skin damage and cancer. Recent studies have shown that UVFs are found in many phases of abiotic and biotic systems with their physical-chemical characteristics determining environmental fate and potential biological impacts such as bioaccumulation. This study developed a unified method to quantify eight UVFs (avobenzone, dioxybenzone, homosalate, octinoxate, octisalate, octocrylene, oxybenzone, and sulisobenzone) by solid phase extraction and ultra-high performance liquid chromatography-tandem mass spectrometry using polarity switching. The validated method resulted in accuracies ranging from 75 to 112%, MLD/MLQs of 0.00015/ 0.00049 to 0.0020/ 0.0067 ng mL-1, and precisions of 1.8 to 22.6% (intraday) and 1.3 to 17.2% (interday). The method was applied to chlorinated outdoor pool waters in the City of Winnipeg, Manitoba, Canada. This method could be adapted for a variety of chlorinated and unchlorinated waters such as drinking water, wastewater, and surface waters.
Asunto(s)
Agua Potable , Contaminantes Químicos del Agua , Humanos , Espectrometría de Masas en Tándem , Protectores Solares/análisis , Cromatografía Líquida de Alta Presión , Canadá , Agua Potable/análisis , Contaminantes Químicos del Agua/análisisRESUMEN
The fate of selected common pharmaceuticals and four of their major conjugates in wastewater batch bioreactors was evaluated to determine how treatment plant parameters such as addition of air, and the presence of waste activated sludge (WAS) could influence the removal of parent compounds and conjugates. Under a realistic hydraulic residence time (HRT) for each treatment sub-process of approximately 2 h, acetaminophen and its sulfate metabolite were both rapidly degraded (>99%). Propranolol was sulfated and concurrently removed. Deconjugation of N-acetylsulfamethoxazole and sulfamethoxazole-glucuronide contributed to increases of the parent sulfamethoxazole. Thyroxine was resistant to degradation, while thyroxine-glucuronide was rapidly deconjugated (>90% in <2 h). In the absence of WAS, sorption to suspended solids was another major removal mechanism for acetaminophen, propranolol, sulfamethoxazole, and thyroxine. However, with WAS, concentrations associated with suspended solids decreased for all analytes within 24 h. These results indicate that both conjugation and back-transformation are compound-specific and dependent on parameters such as HRT, addition of microbial content, and suspended solids levels. Therefore, conjugation-deconjugation processes may strongly influence the speciation of pharmaceuticals and their fate in wastewater treatment plant effluents.
Asunto(s)
Preparaciones Farmacéuticas , Contaminantes Químicos del Agua/análisis , Reactores Biológicos , Humanos , Cinética , Aguas del Alcantarillado , Eliminación de Residuos Líquidos , Aguas Residuales/análisisRESUMEN
Discovery and development of new therapeutic options for the treatment of Mycobacterium tuberculosis (Mtb) infection, particularly drug-resistant strains, are urgently required to tackle the global burden of this disease. Herein, we reported the synthesis of a novel series of N-substituted amino acid hydrazides, utilising a scaffold hopping approach within a library of anti-tubercular agents. Efficacy and selectivity were evaluated against three strains of Mtb (wild-type, isoniazid-resistant and rifampicin-resistant), and cytotoxicity against macrophages in vitro. The antibacterial activity and therapeutic index of these molecules were significantly affected by modifications with the N-substituents. Introduction of a 3,5-dinitroaryl moiety demonstrated enhanced antibacterial activity against all three strains of Mtb. In contrast, the inclusion of an imidazo [1,2-a]pyridine-3-carboxy moiety resulted in enhanced activity towards isoniazid mono-resistant Mtb relative to wild-type Mtb. Consequently, this scaffold hopping approach showed significant promise for exemplification of novel molecules with specific activity profiles against drug-resistant tuberculosis.
Asunto(s)
Antituberculosos/farmacología , Proliferación Celular/efectos de los fármacos , Mycobacterium tuberculosis/efectos de los fármacos , Tuberculosis/tratamiento farmacológico , Sustitución de Aminoácidos/genética , Antituberculosos/química , Humanos , Isoniazida/efectos adversos , Isoniazida/farmacología , Pruebas de Sensibilidad Microbiana , Mycobacterium tuberculosis/patogenicidad , Compuestos Orgánicos/química , Compuestos Orgánicos/farmacología , Rifampin/efectos adversos , Rifampin/farmacología , Relación Estructura-Actividad , Tuberculosis/genética , Tuberculosis/microbiologíaRESUMEN
In response to the Canadian federal government's Cannabis Tracking and Licensing System compliance standards, a quantitative method was created for cannabis analysis, and validated using Eurachem V.2 (2014) guidelines. Cannabinol, cannabidiol, cannabigerol, cannabichromene, cannabidiolic acid, cannabigerolic acid, Δ-9-tetrahydrocannabinol, and Δ-9-tetrahydrocannabinolic acid A were all analysed by scheduled multiple reaction monitoring (MRM) via LC-MS/MS and isotope dilution. In addition, aflatoxins B1, B2, G1, and G2 were also analysed by scheduled MRM via LC-MS/MS and matrix matched calibration curves in order to achieve the reporting limits (≤2⯵gâ¯kg-1) set out by the European Pharmacopoeia. The LODs/LOQs were 0.50/1.7, 2.0/6.7, 0.59/2.0, and 0.53/1.8⯵gâ¯kg-1, for B1, B2, G1, and G2 respectively. Thirty one terpenes were analysed by selected reaction monitoring via GC-MS/MS and isotope dilution using ß-myrcene-d6 as a surrogate. All quantitative analyses can be accomplished using less than 1â¯g of material, with minimal solvent and consumable use, on low resolution instruments in less than 30â¯min of instrument time. Of important note is this method's power of selectivity, working ranges, and lack of need for extraction consumables such as SPE or QuEChERS, thereby minimising analytical costs and time.
Asunto(s)
Aflatoxinas/análisis , Cannabinoides/análisis , Cannabis/química , Contaminación de Medicamentos/prevención & control , Regulación Gubernamental , Adhesión a Directriz , Terpenos/análisis , Canadá , Cromatografía Liquida , Medición de Riesgo , Espectrometría de Masas en TándemRESUMEN
Discovery and development of new therapeutic options for the treatment of Mycobacterium tuberculosis (Mtb) infection are desperately needed to tackle the continuing global burden of this disease and the efficacy and cost limitations associated with current medicines. Herein, we report the synthesis of a series of novel benzoxa-[2,1,3]-diazole substituted amino acid hydrazides in a two-step synthesis and evaluate their inhibitory activity against Mtb and selected bacterial strains of clinical importance utilising an end point-determined REMA assay. Alongside this, their potential for undesired cytotoxicity against mammalian cells was assessed employing standard MTT assay methodologies. It has been demonstrated using modification at three sites (the hydrazine, amino acid, and the benzodiazole) it is possible to change both the antibacterial activity and cytotoxicity of these molecules whilst not affecting their microbial selectivity, making them attractive architectures for further exploitation as novel antibacterial agents.
Asunto(s)
Aminoácidos/química , Antituberculosos/química , Azidas/química , Azoles/química , Hidrazinas/química , Línea Celular Tumoral , Supervivencia Celular/efectos de los fármacos , Diseño de Fármacos , Humanos , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Mycobacterium tuberculosis/efectos de los fármacos , Relación Estructura-ActividadRESUMEN
The intracellular pathogen Mycobacterium tuberculosis is the causative agent of tuberculosis, which is a leading cause of mortality worldwide. The survival of M. tuberculosis in host macrophages through long-lasting periods of persistence depends, in part, on breaking down host cell lipids as a carbon source. The critical role of fatty-acid catabolism in this organism is underscored by the extensive redundancy of the genes implicated in ß-oxidation (â¼100 genes). In a previous study, the enzymology of the M. tuberculosis L-3-hydroxyacyl-CoA dehydrogenase FadB2 was characterized. Here, the crystal structure of this enzyme in a ligand-free form is reported at 2.1â Å resolution. FadB2 crystallized as a dimer with three unique dimer copies per asymmetric unit. The structure of the monomer reveals a dual Rossmann-fold motif in the N-terminal domain, while the helical C-terminal domain mediates dimer formation. Comparison with the CoA- and NAD+-bound human orthologue mitochondrial hydroxyacyl-CoA dehydrogenase shows extensive conservation of the residues that mediate substrate and cofactor binding. Superposition with the multi-catalytic homologue M. tuberculosis FadB, which forms a trifunctional complex with the thiolase FadA, indicates that FadB has developed structural features that prevent its self-association as a dimer. Conversely, FadB2 is unable to substitute for FadB in the tetrameric FadA-FadB complex as it lacks the N-terminal hydratase domain of FadB. Instead, FadB2 may functionally (or physically) associate with the enoyl-CoA hydratase EchA8 and the thiolases FadA2, FadA3, FadA4 or FadA6 as suggested by interrogation of the STRING protein-network database.
Asunto(s)
3-Hidroxiacil-CoA Deshidrogenasas/química , Mycobacterium tuberculosis/enzimología , Cristalografía por Rayos X , Enoil-CoA Hidratasa/metabolismo , Humanos , Oxidación-Reducción , Unión Proteica , Multimerización de ProteínaRESUMEN
Some pharmaceutical conjugates can be excreted into wastewaters at levels rivalling those of the parent compounds; however, little is known about this potential reservoir of pharmaceuticals to aquatic systems. We evaluated the occurrence and distribution of four different classes of pharmaceuticals and their metabolite conjugates in a wastewater treatment plant over four months. Aqueous and suspended solids fractions of primary, mixed liquor, secondary, and final effluent, along with return activated sludge, and waste activated sludge were assessed. The only conjugate not found in the final effluent was acetaminophen sulfate. Moreover, thyroxine and thyroxine glucuronide were the only compounds quantified in the suspended solids in the final effluent. Propranolol, propranolol sulfate, thyroxine, and thyroxine glucuronide all had no significant decreases in concentration going through the wastewater treatment process, from primary to final effluent. However, there were significant decreases observed for acetaminophen (99.8%), sulfamethoxazole (71%), N-acetyl sulfamethoxazole (59%), and sulfamethoxazole glucuronide (79%). The mean (±SEM) mass loadings in the aqueous fraction of the final effluent for each compound ranged from 0.84⯱â¯0.2â¯g/d for thyroxine to 45.3⯱â¯4.2â¯g/d for acetaminophen. At least as much conjugate was released into receiving waters, if not more: 1.6⯱â¯0.2â¯g/d for thyroxine glucuronide to 18.5⯱â¯4.5â¯g/d for sulfamethoxazole glucuronide, and 61.2⯱â¯9.6â¯g/d for N-acetyl sulfamethoxazole. Additionally, the mean loading of thyroxine was 0.29⯱â¯0.025â¯g/day and thyroxine glucuronide 1.8⯱â¯0.59â¯g/day in the suspended solids. This equates to 26% of total thyroxine and 53% of total thyroxine glucuronide associated with suspended particulate matter that reaches receiving waters. This study reflects the importance of including phase II conjugates in assessing overall compound load of pharmaceutical discharge from wastewaters, and also that substantial amounts of such contaminants are associated with wastewater solids when drugs are in the pg/L to µg/L range.
Asunto(s)
Preparaciones Farmacéuticas , Contaminantes Químicos del Agua , Aguas del Alcantarillado , Sulfametoxazol , Sulfatos , Eliminación de Residuos Líquidos , Aguas ResidualesRESUMEN
The treatment performance and bacterial community structure of conventional activated sludge and aerobic granules exposed to antibiotic sulfamethoxazole (SMX) was studied. For three months, two sets of sequencing batch reactors inoculated with conventional and granular biomass were fed with a synthetic municipal wastewater containing 2⯵g/L SMX. The presence of SMX had no significant impacts on treatment performance of the reactors as well as stability of the granules. Results confirmed different bacterial community structure of flocs and granules. During the operation, variations in bacterial community structure of suspended and granular sludge were observed in all reactors. The variations in bacterial community composition due to the exposure to 2⯵g/L SMX were found after two months in both suspended and granular biomass. Nitrosomonas, Pseudomonas, and Acinetobacter were detected as the genes capable of degrading SMX in both biomass types. Also, Rikenellaceae, Oscillospira, Rhodocyclaceae, Zoogloea, and Shewanella varied in abundance over the operation time. Rikenellaceae and Oscillospira were vulnerable to SMX and decreased in abundance the operation time; while Rhodocyclaceae, Zoogloea, Shewanella, and Aeromonas were found as SMX resistance genes.
Asunto(s)
Reactores Biológicos , Sulfametoxazol , Eliminación de Residuos Líquidos , Aerobiosis , Antibacterianos , Bacterias/crecimiento & desarrollo , Aguas del Alcantarillado , Aguas ResidualesRESUMEN
This study investigates the removal of the antibiotic sulfamethoxazole (SMX) in two sets of anoxic/anaerobic/oxic sequencing batch reactors inoculated with either suspended or granular activated sludge. Continuously, for three months, 2⯵g/L SMX was spiked into the reactor feeds in a synthetic municipal wastewater with COD, total nitrogen (TN) and total phosphorous (TP) of 400, 43 and 7â¯mg/L, respectively. The presence of SMX had no significant impact on treatment performance of the suspended and granular biomass. After 12â¯h of hydraulic retention time, SMX removal efficiencies of 84 and 73% were obtained for the granular and suspended biomass, respectively. Mixing without aeration did not remove SMX, confirming the insignificance of SMX removal via sorption. The pseudo-first order SMX removal rate constants in the granular and suspended biomass were 2.25⯱â¯0.30 and 1.34⯱â¯0.39â¯L/gVSS·d, respectively. The results suggest that granules with advantages such as elevated biomass retention and greater biomass concentration could be effective for the removal of this class of antibiotics.
Asunto(s)
Antibacterianos , Reactores Biológicos , Sulfametoxazol , Eliminación de Residuos Líquidos , Nitrógeno , Aguas del AlcantarilladoRESUMEN
A solids extraction method, using sonication in combination with weak anion exchange solid phase extraction, was created to extract thyroxine (T4) and thyroxine-O-ß-d-glucuronide (T4-Glc) simultaneously from wastewaters and sludges, and to quantify these compounds via reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry. The method limits of quantification were all in the low ng/g (dry weight solids) range for both T4 and T4-Glc: 2.13 and 2.63ng/g respectively in primary wastewater, 4.3 and 28.3ng/g for primary suspended solids, for 1.1 and 3.7ng/g for return activated sludge. Precision for measurements of T4 and T4-Glc were 2.6 and 6.5% (intraday) and 9.6 and 5.7% (interday) respectively, while linearity was 0.9967 and 0.9943 respectively. Overall recoveries for T4 and T4-Glc in primary suspended solids were 94% and 95%, and 86 and 101% in primary wastewater, respectively. Extraction efficiency tests using primary sludge determined that one methanol aliquot was sufficient during the extraction process as opposed to 2 or 3 aliquots. Mass loadings at the North Main Wastewater Treatment Plant in Winnipeg, Canada showed 316%, 714%, and 714% greater T4-Glc than T4 associated with the suspended solids of the primary, secondary, and final effluent respectively, yet 765% more T4 than T4-Glc associated with the solids of the mixed liquor. Moreover, 26% of T4 and 49% of T4-Glc were associated with the suspended solids during the treatment process. This method demonstrates the need to assess accurately both metabolite conjugates of contaminants of emerging concern, as well as the sorbed levels of particle-reactive analytes such as T4 in the aquatic environment.
Asunto(s)
Técnicas de Química Analítica/métodos , Cromatografía Líquida de Alta Presión , Glucurónidos/análisis , Extracción en Fase Sólida , Espectrometría de Masas en Tándem , Tiroxina/análisis , Aguas Residuales/química , Canadá , Aguas del Alcantarillado/química , Sonicación , Contaminantes Químicos del Agua/análisisRESUMEN
The neuroleptic drug thioridazine has been recently repositioned as possible anti-tubercular drug. Thioridazine showed anti-tubercular activity against drug resistant mycobacteria but it is endowed with adverse side effects. A small library of thioridazine derivatives has been designed through the replacement of the piperidine and phenothiazine moieties, with the aim to improve the anti-tubercular activity and to reduce the cytotoxic effects. Among the resulting compounds, the indole derivative 12e showed an antimycobacterial activity significantly better than thioridazine and a cytotoxicity 15-fold lower.
Asunto(s)
Antituberculosos/síntesis química , Antituberculosos/farmacología , Diseño de Fármacos , Resistencia a Múltiples Medicamentos/efectos de los fármacos , Mycobacterium tuberculosis/efectos de los fármacos , Tioridazina/síntesis química , Tioridazina/farmacología , Antituberculosos/química , Línea Celular , Técnicas de Química Sintética , Humanos , Relación Estructura-Actividad , Tioridazina/químicaRESUMEN
Recent data suggests there are non-trivial amounts of human pharmaceutical conjugates potentially entering environmental surface waters. These compounds could contribute to eliciting toxic effects on aquatic biota either directly or indirectly, via de-conjugation. The need for developing a single method for quantifying both parents and conjugates is necessary. Propranolol (PRO), sulfamethoxazole (SMX), and their respective major conjugates 4-OH-propranolol sulfate (PRO-Sul) and sulfamethoxazole-ß-glucuronide (SMX-Glc) were successfully simultaneously extracted through weak anion exchange solid phase extraction cartridges from primary and secondary clarification wastewaters from the North End Winnipeg Water Pollution Treatment Plant in Winnipeg, Canada. Subsequent separation and quantification were achieved by reversed-phase C18 chromatography coupled to positive electrospray ionisation tandem mass spectrometry. Linearity for all compounds throughout the 7-point calibration range was >0.99. Recovery RSD ranges across all matrices for PRO, SMX, PRO-Sul, and SMX-Glc were 2.1-13.2%, 2.3-10.2%, 9.8-19.2%, and 2.0-10.3% respectively. Primary and secondary filtrates respectively showed a significant increase of PRO from 0.039 to 0.045µg/L; a significant decrease for SMX from 1.56 to 0.58µg/L; significant decrease of PRO-Sul from 0.050 to 0.020µg/L; and a significant decrease of SMX-Glc from 0.41 to 0.019µg/L. These observations indicate that there was removal of all compounds, except for PRO, from the aqueous phase occurring at some point between the stages of treatment. To our knowledge, this is first study that simultaneously separated and quantified two different classes of parent compounds and two different kinds of human metabolite conjugates (glucuronide and sulfate) from a major urban wastewater treatment plant.
Asunto(s)
Técnicas de Química Analítica/métodos , Aguas Residuales/química , Contaminantes Químicos del Agua/análisis , Canadá , Glucurónidos/análisis , Humanos , Propranolol/análogos & derivados , Propranolol/análisis , Extracción en Fase Sólida , Espectrometría de Masa por Ionización de Electrospray , Sulfametoxazol/análisis , Sulfatos/análisis , Espectrometría de Masas en Tándem , Purificación del Agua/normasRESUMEN
Novel pyrroles have been designed, synthesized, and evaluated against mycobacterial strains. The pyrroles have originally been designed as hybrids of the antitubercular drugs BM212 (1) and SQ109 (2), which showed common chemical features with very similar topological distribution. A perfect superposition of the structures of 1 and 2 revealed by computational studies suggested the introduction of bulky substituents at the terminal portion of the pyrrole C3 side chain and the removal of the C5 aryl moiety. Five compounds showed high activity toward Mycobacterium tuberculosis, while 9b and 9c were highly active also against multidrug-resistant clinical isolates. Compound 9c showed low eukaryotic cell toxicity, turning out to be an excellent lead candidate for preclinical trials. In addition, four compounds showed potent inhibition (comparable to that of verapamil) toward the whole-cell drug efflux pump activity of mycobacteria, thus turning out to be promising multidrug-resistance-reversing agents.
Asunto(s)
Adamantano/análogos & derivados , Antituberculosos/síntesis química , Antituberculosos/farmacología , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Etilenodiaminas/síntesis química , Etilenodiaminas/farmacología , Mycobacterium tuberculosis/efectos de los fármacos , Piperazinas/síntesis química , Piperazinas/farmacología , Pirroles/síntesis química , Pirroles/farmacología , Adamantano/síntesis química , Adamantano/farmacología , Proteínas Portadoras/efectos de los fármacos , Línea Celular , Supervivencia Celular/efectos de los fármacos , Biología Computacional , Diseño de Fármacos , Humanos , Pruebas de Sensibilidad Microbiana , Modelos Moleculares , Mycobacterium/efectos de los fármacos , Preparaciones Farmacéuticas/metabolismo , Relación Estructura-ActividadRESUMEN
A probabilistic ecological risk assessment was conducted for the transformation products (TPs) of 3 ß-blockers (atenolol, metoprolol, and propranolol) and 5 selective serotonin reuptake inhibitors (SSRIs; citalopram, fluoxetine, fluvoxamine, paroxetine, and sertraline) to assess potential threats to aquatic organisms in effluent-dominated surface waters. To this end, the pharmacokinetic literature, the University of Minnesota's Biocatalysis/Biodegradation Database Pathway Prediction System aerobic microbial degradation software, and photolysis literature pertaining to ß-blockers and SSRIs were used to determine their most likely TPs formed via human metabolism, aerobic biodegradation, and photolysis, respectively. Monitoring data from North American and European surface waters receiving human wastewater inputs were the basis of the exposure characterizations of the parent compounds and the TPs, where available. In most cases, where monitoring data for TPs did not exist, we assumed a conservative 1:1 parent-to-TP production ratio (i.e., 100% of parent converted). The US Environmental Protection Agency (USEPA)'s EPISuite and ECOSAR v1.11 software were used to estimate acute and chronic toxicities to aquatic organisms. Hazard quotients, which were calculated using the 95(th) percentile of the exposure distributions, ranged from 10(-11) to 10(-3) (i.e., all significantly less than 1). Based on these results, the TPs of interest would be expected to pose little to no environmental risk in surface waters receiving wastewater inputs. Overall, we recommend developing analytical methods that can isolate and quantify human metabolites and TPs at environmentally relevant concentrations to confirm these predictions. Further, we recommend identifying the major species of TPs from classes of pharmaceuticals that could elicit toxic effects via specific modes of action (e.g., norfluoxetine via the serotonin 5-hydroxytryptamine [5-HT]1A receptors) and conducting aquatic toxicity tests to confirm these findings. To our knowledge, this is the first quantitative probabilistic ecotoxicological assessment of all of the predicted and probable TPs of these pharmaceuticals, and our approach provides a framework for future such studies with other compound classes as data become available.
Asunto(s)
Antagonistas Adrenérgicos beta/análisis , Monitoreo del Ambiente , Inhibidores Selectivos de la Recaptación de Serotonina/análisis , Aguas Residuales/química , Contaminantes Químicos del Agua/análisis , Antagonistas Adrenérgicos beta/toxicidad , Organismos Acuáticos , Medición de Riesgo , Inhibidores Selectivos de la Recaptación de Serotonina/toxicidad , Estados Unidos , Eliminación de Residuos Líquidos , Contaminantes Químicos del Agua/toxicidadRESUMEN
The highly persistent and often lethal human pathogen, Mycobacterium tuberculosis contains at least 88 toxin-antitoxin genes. More than half of these encode VapC PIN domain endoribonucleases that inhibit cell growth by unknown mechanisms. Here we show that VapC20 of M. tuberculosis inhibits translation by cleavage of the Sarcin-Ricin loop (SRL) of 23S ribosomal RNA at the same position where Sarcin and other eukaryotic ribotoxins cleave. Toxin-inhibited cells can be rescued by the expression of the antitoxin, thereby raising the possibility that vapC20 contributes to the extreme persistence exhibited by M. tuberculosis. VapC20 cleavage is inhibited by mutations in the SRL that flank the cleavage site but not by changes elsewhere in the loop. Disruption of the SRL stem abolishes cleavage; however, further mutations that restore the SRL stem structure restore cleavage, revealing that the structure rather than the exact sequence of the SRL is important for this activity.
Asunto(s)
Proteínas Bacterianas/metabolismo , Endorribonucleasas/metabolismo , Proteínas Fúngicas/metabolismo , Mycobacterium tuberculosis/enzimología , ARN Ribosómico 23S/metabolismo , Ricina/metabolismo , Factores de Virulencia/toxicidad , Proteínas Bacterianas/química , Proteínas Bacterianas/toxicidad , Endorribonucleasas/antagonistas & inhibidores , Endorribonucleasas/química , Endorribonucleasas/genética , Proteínas Fúngicas/química , Mutación , ARN Ribosómico 23S/química , Ricina/química , Factores de Virulencia/químicaRESUMEN
The lipid-rich cell wall of mycobacteria is essential not only for virulence but also for survival. Whilst anabolic pathways for mycobacterial lipid biosynthesis have been well studied, there has been little research looking into lipid catabolism. The genome of Mycobacterium tuberculosis encodes multiple enzymes with putative roles in the beta-oxidation of fatty acids. In this report we explore the functionality of FadB2, one of five M. tuberculosis homologues of a beta-hydroxybutyryl-CoA dehydrogenase, an enzyme that catalyses the third step in the beta-oxidation cycle. Purified M. tuberculosis FadB2 catalysed the in vitro NAD(+)-dependent dehydration of beta-hydroxybutyryl-CoA to acetoacetyl-CoA at pH 10. Mutation of the active-site serine-122 residue resulted in loss of enzyme activity, consistent with the function of FadB2 as a fatty acyl dehydrogenase involved in the beta-oxidation of fatty acids. Surprisingly, purified FadB2 also catalysed the reverse reaction, converting acetoacetyl-CoA to beta-hydroxybutyryl-CoA, albeit in a lower pH range of 5.5-6.5. Additionally, a null mutant of fadB2 was generated in Mycobacterium smegmatis. However, the mutant showed no significant differences from the wild-type strain with regard to lipid composition, utilization of different fatty acid carbon sources and tolerance to various stresses; the absence of any phenotype in the mutant strain could be due to the potential redundancy between the five M. smegmatis fadB paralogues.
Asunto(s)
3-Hidroxiacil-CoA Deshidrogenasas/química , 3-Hidroxiacil-CoA Deshidrogenasas/metabolismo , Proteínas Bacterianas/química , Proteínas Bacterianas/metabolismo , Mycobacterium tuberculosis/enzimología , 3-Hidroxiacil-CoA Deshidrogenasas/genética , Acilcoenzima A/metabolismo , Secuencia de Aminoácidos , Proteínas Bacterianas/genética , Estabilidad de Enzimas , Datos de Secuencia Molecular , Mutación , Mycobacterium tuberculosis/química , Mycobacterium tuberculosis/genética , NAD/metabolismo , Alineación de SecuenciaRESUMEN
BACKGROUND: There is an urgent need for the discovery and development of new drugs against Mycobacterium tuberculosis, the causative agent of tuberculosis, especially due to the recent emergence of multi-drug and extensively-drug resistant strains. Herein, we have examined the susceptibility of mycobacteria to the natural product platensimycin. METHODS AND FINDINGS: We have demonstrated that platensimycin has bacteriostatic activity against the fast growing Mycobacterium smegmatis (MIC = 14 microg/ml) and against Mycobacterium tuberculosis (MIC = 12 microg/ml). Growth in the presence of paltensimycin specifically inhibited the biosynthesis of mycolic acids suggesting that the antibiotic targeted the components of the mycolate biosynthesis complex. Given the inhibitory activity of platensimycin against beta-ketoacyl-ACP synthases from Staphylococcus aureus, M. tuberculosis KasA, KasB or FabH were overexpressed in M. smegmatis to establish whether these mycobacterial KAS enzymes were targets of platensimycin. In M. smegmatis overexpression of kasA or kasB increased the MIC of the strains from 14 microg/ml, to 30 and 124 microg/ml respectively. However, overexpression of fabH on did not affect the MIC. Additionally, consistent with the overexpression data, in vitro assays using purified proteins demonstrated that platensimycin inhibited Mt-KasA and Mt-KasB, but not Mt-FabH. SIGNIFICANCE: Our results have shown that platensimycin is active against mycobacterial KasA and KasB and is thus an exciting lead compound against M. tuberculosis and the development of new synthetic analogues.
Asunto(s)
3-Oxoacil-(Proteína Transportadora de Acil) Sintasa/antagonistas & inhibidores , Adamantano/farmacología , Aminobenzoatos/farmacología , Anilidas/farmacología , Inhibidores Enzimáticos/farmacología , Isoenzimas/antagonistas & inhibidores , Mycobacterium smegmatis/enzimología , Mycobacterium tuberculosis/enzimología , Secuencia de Bases , Cartilla de ADN , Ácidos Grasos/antagonistas & inhibidores , Ácidos Grasos/biosíntesis , Ácidos Micólicos/antagonistas & inhibidores , Ácidos Micólicos/metabolismoRESUMEN
BACKGROUND: Tuberculosis (TB) is a disease which kills two million people every year and infects approximately over one-third of the world's population. The difficulty in managing tuberculosis is the prolonged treatment duration, the emergence of drug resistance and co-infection with HIV/AIDS. Tuberculosis control requires new drugs that act at novel drug targets to help combat resistant forms of Mycobacterium tuberculosis and reduce treatment duration. METHODOLOGY/PRINCIPAL FINDINGS: Our approach was to modify the naturally occurring and synthetically challenging antibiotic thiolactomycin (TLM) to the more tractable 2-aminothiazole-4-carboxylate scaffold to generate compounds that mimic TLM's novel mode of action. We report here the identification of a series of compounds possessing excellent activity against M. tuberculosis H(37)R(v) and, dissociatively, against the beta-ketoacyl synthase enzyme mtFabH which is targeted by TLM. Specifically, methyl 2-amino-5-benzylthiazole-4-carboxylate was found to inhibit M. tuberculosis H(37)R(v) with an MIC of 0.06 microg/ml (240 nM), but showed no activity against mtFabH, whereas methyl 2-(2-bromoacetamido)-5-(3-chlorophenyl)thiazole-4-carboxylate inhibited mtFabH with an IC(50) of 0.95+/-0.05 microg/ml (2.43+/-0.13 microM) but was not active against the whole cell organism. CONCLUSIONS/SIGNIFICANCE: These findings clearly identify the 2-aminothiazole-4-carboxylate scaffold as a promising new template towards the discovery of a new class of anti-tubercular agents.
Asunto(s)
3-Oxoacil-(Proteína Transportadora de Acil) Sintasa/antagonistas & inhibidores , Antituberculosos/farmacología , Mycobacterium tuberculosis/efectos de los fármacos , Tiazoles/farmacología , Antituberculosos/síntesis química , Antituberculosos/química , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Mycobacterium tuberculosis/enzimología , Tiazoles/síntesis química , Tiazoles/químicaRESUMEN
Mycolic acids are hallmark features of the Mycobacterium tuberculosis cell wall. They are synthesized by the condensation of two fatty acids, a C56-64-meromycolyl chain and a C24-26-fatty acyl chain. Meromycolates are produced via the combination of type I and type II fatty acid synthases (FAS-I and FAS-II). The beta-ketoacyl-acyl carrier protein (ACP) synthase III (mtFabH) links FAS-I and FAS-II, catalyzing the condensation of FAS-I-derived acyl-CoAs with malonyl-ACP. Because mtFabH represents a potential regulatory key point of the mycolic acid pathway, we investigated the hypothesis that phosphorylation of mtFabH controls its activity. Phosphorylation of proteins by Ser/Thr protein kinases (STPKs) has recently emerged as a major physiological mechanism of regulation in prokaryotes. We demonstrate here that mtFabH was efficiently phosphorylated in vitro by several mycobacterial STPKs, particularly by PknF and PknA, as well as in vivo in mycobacteria. Analysis of the phosphoamino acid content indicated that mtFabH was phosphorylated exclusively on threonine residues. Mass spectrometry analyses using liquid chromatography-electrospray ionization/tandem mass spectrometry identified Thr45 as the unique phosphoacceptor. This was further supported by complete loss of PknF- or PknA-dependent phosphorylation of a mtFabH mutant. Mapping Thr45 on the crystal structure of mtFabH illustrates that this residue is located at the entrance of the substrate channel, suggesting that the phosphate group may alter accessibility of the substrate and thus affect mtFabH enzymatic activity. A T45D mutant of mtFabH, designed to mimic constitutive phosphorylation, exhibited markedly decreased transacylation, malonyl-AcpM decarboxylation, and condensing activities compared with the wild-type protein or the T45A mutant. Together, these findings not only represent the first demonstration of phosphorylation of a beta-ketoacyl-ACP synthase III enzyme but also indicate that phosphorylation of mtFabH inhibits its enzymatic activity, which may have important consequences in regulating mycolic acid biosynthesis.